TITLE

Letter: Intranasal administration of synthetic gonadotrophin-releasing hormone

AUTHOR(S)
Jeppsson, S; Kullander, S; Rannevik, G; Thorell, J
PUB. DATE
October 1973
SOURCE
British Medical Journal;10/27/1973, Vol. 4 Issue 5886, p231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108655

 

Related Articles

  • A stop (discontinued) GnRHa regimen in in vitro fertilization. Waldenström, Urban; Hellberg, Dan; Nilsson, Staffan // Archives of Gynecology & Obstetrics;Aug2005, Vol. 272 Issue 2, p182 

    Presents a letter to the editor about gonadotrophin-releasing hormone agonists regimen in in vitro fertilization.

  • gonadorelin.  // Royal Society of Medicine: Medicines;2002, p272 

    This article presents information on gonadorelin, the hypothalamic hormone that acts on the pituitary gland to release the gonadotrophin hormones. It is therefore also known as luteinising hormone-releasing hormone. Gonadorelin is in fact the synthetic version of naturally occurring...

  • Effect of Thyrotropin-Releasing Hormone and Its Synthetic Analogue Digipramine on Certain Indices of Hemostasis in vitro and in vivo. Grigorjeva, M. E.; Golubeva, M. G. // Biology Bulletin;May2005, Vol. 32 Issue 3, p254 

    The effect of neuropeptide thyrotropin-releasing hormone (TRH) and its synthetic analogue digipramine on certain indices of blood coagulation and fibrinolysis were studied in vitro and in vivo. The peptides added to the pool of normal rat plasma at 10−10 to 10−3 M increased the...

  • GYNECOLOGY -- POLYCYSTIC OVARY SYNDROME.  // Current Medical Literature: Gynecology & Obstetrics;2005, Vol. 11 Issue 1, p12 

    Discusses several research on polycystic ovary syndrome published in 2005. "Effect of Implanon on Insulin Resistance in Women With Polycystic Ovary Syndrome," by C. Meyer et al.; "Prevalence of Insulin Resistance in the Polycystic Ovary Syndrome Using the Homeostasis Model Assessment," by C. M....

  • Udder angst. Kennedy, Dan // Garbage;Summer94, Vol. 6 Issue 2, p40 

    Focuses on the controversy over synthetic bovine growth hormone's health effects in the United States. Possible benefits of bovine growth hormone; US Food and Administration's approval of bovine growth hormone; Biotechnology's opposition to the hormone.

  • New GnRH-blocker for advanced prostate cancer.  // British Journal of Hospital Medicine (17508460);Apr2009, Vol. 70 Issue 4, p189 

    The article reports on the launch of the Degarelix, a new gonadotrophin-releasing hormone receptor blocker for the treatment of patients with advanced hormone-dependent prostate cancer.

  • Activity.  // Winner;Oct96, Vol. 40 Issue 2, p5 

    Presents a word puzzle in which readers are asked to unscramble letters to find a version of a male hormone synthetic steroid.

  • Ways to beat PMS.  // Marie Claire (US Edition);Feb2002, Vol. 9 Issue 2, p156 

    Details treatments for premenstrual syndrome. Administration of synthetic hormones; Efficacy of Vitex and meditation; Description of appropriate diet.

  • Intranasal versus Injectable Influenza Vaccine. Genton, Blaise; D'Acremont, Valérie // Clinical Infectious Diseases;9/1/2004, Vol. 39 Issue 5, p754 

    Presents letters to the editor on the safety of intranasal influenza vaccines.

  • Dose of 0.5mg Daily Does Not Prevent Premature LH Surge.  // Fertility Weekly;10/13/2008, p4 

    The article presents a research which shows that cetrorelix is related to high incidence of premature luteinizing hormone (LH) surge event at a 0.5 milligram (mg) dosage. The study was conducted to identify if the administration of the gonadotrophin-releasing hormone (GnRH) antagonist cetrorelix...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics